| |
 |
Christos Tsaklakidis Patents |
|
Inventor: Tsaklakidis; Christos
Address: Weinheim, DE
No. of patents: 19
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7273867 |
Phenyl derivatives |
September 25, 2007 |
| Novel compounds of the formula I in which W, X, Y, T, R.sup.1 and R.sup.2 are as defined in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders ##STR00001## |
| 7199133 |
Derivatives of phenoxy-n-'4-(isothiazolindin-1, 1-dioxid-2yl)phenyll-valerian-acid amide and oth |
April 3, 2007 |
| Novel compounds of formula (I), wherein D, W, X, Y, T and R.sup.1 have the meanings cited in claim 1, are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumors ##STR00001## |
| 7183277 |
Carboxylic acid amides |
February 27, 2007 |
| Novel compounds of the formula I ##STR00001## in which D, W, X, Y, T and R.sup.1 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours. |
| 6946489 |
Substituted biphenyl derivatives |
September 20, 2005 |
| The invention relates to compounds of the formula I ##STR1##in which R.sup.1, R.sup.2, R.sup.3, R.sup.4 and X have the meaning indicated in the text. The compounds act as inhibitors of factors Xa and VIIa and can therefore be employed for the control and prevention of thromboembolic |
| 6943179 |
Biurethane derivatives |
September 13, 2005 |
| Novel compounds of the formula I in which X, Y, Z, R, R.sup.1, R.sup.2 and R.sup.3 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of tromboembolic diseases and for the treatment of tumors ##STR1## |
| 6849626 |
Aza-amino acid derivatives (factor Xa inhibitors 15) |
February 1, 2005 |
| The invention relates to semicarbazides of the general formula I ##STR1##where R.sup.1, R.sup.2, R.sup.3, R.sup.4 and I have the meaning indicated in claim 1.The compounds of the formula I can be employed as pharmaceutical active compounds in human and veterinary medicine, in particular |
| 6673816 |
Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorde |
January 6, 2004 |
| Compounds of general formula (I), in which m is 0-8, q is a 0-8, a is 0-4, A signifies a single or double bond, R.sub.1, R.sub.2 signify hydrogen or lower alkyl and, when m signifies 2-8, R.sub.1 and R.sub.2 in the group CR.sub.1.dbd.CR.sub.2 can have various significances within the fol |
| 5972947 |
Oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents contai |
October 26, 1999 |
| The present invention concerns new oxazolidinone derivatives, processes for their production as well as pharmaceutical agents containing these substances. The present invention concerns compounds of the general formula I ##STR1## in which the symbols have the meanings as listed i |
| 5856309 |
Amidinopyrroline derivatives, processes for their production and pharmaceutical agents containin |
January 5, 1999 |
| Compound of formula (I) are disclosed ##STR1## as well as optically active isomers or pharmacologically acceptable salts thereof. The compounds are useful active ingredients in pharmaceutical compositions, and methods of treating osteoporosis, inflammation or diseases which are d |
| 5786371 |
Pyridine and pyridazine derivatives, processes for the production thereof and pharmaceutical age |
July 28, 1998 |
| Compounds of Formula I ##STR1## in which the variables are defined herein, processes for the production thereof as well as pharmaceutical agents containing these compounds for the treatment of diseases which are the result of thromboembolytic events. |
| 5698541 |
2,4-diphosphonoglutaric acid derivatives, processes for their production and pharmaceutical agen |
December 16, 1997 |
| The invention concerns compounds of the general formula I ##STR1## in which R denotes a lower alkyl which can be substituted if desired by hydroxy, alkoxy, amino, dialkylamino, alkylmercapto, alkylsulfinyl, alkanesulfonyl, cycloalkyl, aryl or a heterocyclic ring, or it denotes lo |
| 5683994 |
Phosphosuccinic acid derivatives, processes for the production thereof and pharmaceutical agents |
November 4, 1997 |
| Compounds of formula I are disclosed, ##STR1## as well as processes for their production and pharmaceutical agents containing these compounds suitable for treating disorders of calcium metabolism. |
| 5627170 |
Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contai |
May 6, 1997 |
| Compounds of the formula I ##STR1## in which R signifies a possibly substituted amino group of the general formula --NR.sup.1 R.sup.2, whereby, independently of one another, R.sup.1 and R.sup.2 each signify hydrogen, lower alkyl, lower alkenyl or lower alkynyl or R represents a s |
| 5538957 |
Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing t |
July 23, 1996 |
| Compounds of the formula (I) in which: R is a possibly substituted amino group of the general form --NR.sub.1 R.sub.2, in which R.sub.1 and R.sub.2 are independently hydrogen, lower alkyl, lower alkenyl or lower alkinyl, or R is a saturated, unsaturated or aromatic heterocyclic ring whic |
| 4999361 |
Trisubstituted amines, pharmacologically acceptable salts thereof and pharmaceutical composition |
March 12, 1991 |
| The present invention provides compounds of the general formula ##STR1## wherein R.sub.1 is a hydrogen atom, a straight-chained or branched C.sub.1 -C.sub.12 -alkyl radical, a C.sub.3 -C.sub.7 -cycloalkyl radical, a straight-chained or branched C.sub.2 -C.sub.12 -alkenyl radical or a |
| 4996219 |
Imidazolidine derivatives as immunosuppressives |
February 26, 1991 |
| The present invention provides compounds of the general formulae: ##STR1## wherein R.sub.1 and R.sub.2, which can be the same or different, are hydrogen atoms or C.sub.1 -C.sub.5 -alkyl radicals, C.sub.3 -C.sub.5 -alkenyl radicals or phenyl radicals or, together with the carbon atom |
| 4937337 |
Substituted heterocyclic compounds and the pharmacologically acceptable salts thereof, processes |
June 26, 1990 |
| The present invention provides compounds of the general formula: ##STR1## wherein R.sub.1 is a straight-chained or branched C.sub.1 -C.sub.12 -alkyl radical which can be substituted by a phenyl, naphthyl or C.sub.3 -C.sub.7 -cycloalkyl radical, a straight-chained or branched C.sub.2 |
| 4927834 |
1,2-diamino compounds, processes for their preparation and pharmaceutical compositions containin |
May 22, 1990 |
| The present invention provides compounds of the general formula: ##STR1## wherein R.sub.1 is a straight-chained or branched C.sub.1 -C.sub.12 -alkyl radical which can be substituted by phenyl, naphthyl or a C.sub.3 -C.sub.7 -cycloalkyl radical; a straight-chained or branched C.sub.2 |
| 4923889 |
1,2-diamino compounds, process for their preparation and pharmaceutical compositions containing |
May 8, 1990 |
| Compounds are disclosed, including 2-diethylamino-3-isobutoxy-N-phenyl-N-2-furanyl-methyl-propylamine and compounds of the formula: ##STR1## wherein R.sub.1 is an iso-C.sub.4 -C.sub.6 -alkyl radical; A is a valency bond or a straight-chained or branched alkyl radical containing u |
|
|
|
